BILLS-109hr4082ih.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (14)
4082
years
OCTOBER 19, 2005
1986
3 month
1ST SESSION H. R. 4082
year
2005
3-YEAR
2-year
20
year
each year
the taxable year
1 year
GPE (3)
the United States of America
Massachusetts
Pennsylvania
LOC (1)
IH
NORP (1)
Cosmetic
ORG (11)
House of Representa-
CONGRESS
SEC
the Committee on Ways
and
THE HOUSE OF REPRESENTATIVES
Senate
the Internal Revenue Code
GENERAL.—If
the ‘‘Biotechnology Future
the Federal Food, Drug
PERSON (6)
HAYWORTH
RULE.—In
REYNOLDS
GERLACH
NEAL
HART
Topic Classifications
congressional legislation
97.3%
financial regulation
34.4%
government oversight
14.9%
Extracted Keywords
biomedical research
biomedical
qualified investment
stock
debt
closing
corporation
transaction
research
vestment
investment
corpora tion
corpora
loss
measuring
Forensic Analysis
Classification Stamps
EXEMPT
PDF Metadata
- Creator
- ACOMP.exe WinVer 1c15 Aug 31 2005
- ModDate
- D:20230112020629Z
- Producer
- Acrobat Distiller 4.0 for Windows; modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20051022044304Z
Sentiment
Polarity
Neutral
0.034
Subjectivity
39%
Objective
No crisis correlations found for this document.
The ML pipeline may still be processing.